# Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer

> **NCT01830270** · PHASE2 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 30 (actual)

## Conditions studied

- Stomach Neoplasms
- Oesophageal Junction Cancer
- Lower Oesophagus Cancer

## Interventions

- **DRUG:** Epirubicin
- **DRUG:** Cisplatin
- **DRUG:** Paclitaxel
- **PROCEDURE:** gastric surgery

## Key facts

- **NCT ID:** NCT01830270
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2015-04
- **Final completion:** 2016-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830270, "Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01830270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*